Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma and of Its Treatment With Sorafenib (GIDEON)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00812175
Recruitment Status : Completed
First Posted : December 22, 2008
Last Update Posted : October 17, 2016
Information provided by (Responsible Party):

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : April 2012
  Study Completion Date : April 2012
Publications of Results:
Publications automatically indexed to this study by Identifier (NCT Number):